M&ACNBC-TV18
AstraZeneca India signs LoI with Reliance's Strand
Positive+67
GreyOak summary
AstraZeneca Pharma India signed a letter of intent with Strand Life Sciences, a Reliance subsidiary, to explore healthcare collaboration opportunities. The deal does not specify the partnership scope. AstraZeneca shares rose 2.4% following the announcement, which comes after the company reported a 14.9% increase in Q2 net profit.
What it affects
- AstraZeneca Pharma IndiaASTRAZENPositive +67
Signed LoI with Reliance's Strand Life Sciences.Rolling sentiment Positive +42
- HealthcarePositive +67
Sector of proposed collaboration.Rolling sentiment Positive +40
- Reliance IndustriesRELIANCEPositive +23
Rolling sentiment Positive +35
Source
Read the original at CNBC-TV18More AstraZeneca Pharma India news
No other recent stories about AstraZeneca Pharma India.
All AstraZeneca Pharma India news →